Visit the 2022-2023 Seasonal Influenza Resource Center
Influenza is a highly contagious viral infection. There are three main antigen types of influenza: types A, B, and C. Influenza type A causes moderate to severe illness and affects all age groups. Type A can infect both humans and animals. The notion that influenza type B generally causes milder disease than type A has been recently challenged and is more fatal in children. Type B mainly infects humans. Influenza type C only causes mild respiratory illness. Influenza activity peaks from December to March in the Northern Hemisphere.
Influenza is transmitted from person to person mainly when an infected person coughs or sneezes. Transmission can also occur from direct contact with respiratory secretions, such as when touching surfaces contaminated with influenza virus and then touching the eyes, nose, or mouth, or from indirect contact with droplets from coughs or sneezes. Transmission can occur from the day before symptoms begin until about 5 days after symptoms begin in adults, or up to 10 days or more after symptoms begin in children.
About 50% of infected persons will develop "classic" influenza disease. This is characterized by the abrupt onset of fever, muscle pain, sore throat, nonproductive cough, runny nose, and headache. These symptoms generally last from 2 to 3 days. However, some people may experience a loss of strength or energy for several weeks. In addition, some people may develop complications, such as pneumonia.
Source: Centers for Disease Control and Prevention
You also may be interested in...
Publication
9/15/2022
The purpose of this standing order is to reduce morbidity and mortality from influenza by vaccinating children and adolescents who meet the criteria established by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) and the Department of Defense (DOD).
Recommended Content:
Influenza, Northern Hemisphere
Report
8/27/2021
Updated vaccine recommendations for the 2020-21 influenza season. Routine annual influenza vaccination is recommended for all persons 6 months and older who do not have contraindications.
Recommended Content:
Influenza, Northern Hemisphere
Fact Sheet
8/19/2021
The purpose of this information paper is to describe influenza disease and supporting vaccines to prevent its spread.
Recommended Content:
Influenza, Northern Hemisphere
Publication
5/14/2020
The U.S. Army Medical Materiel Agency Distribution Operations Center (USAMMA DOC) provides disposition guidance on the expired/expiring 2019-2020 influenza vaccine.
Recommended Content:
Influenza, Northern Hemisphere
Publication
5/12/2020
A pre-designed reminder card for parents whose children are being immunized against influenza for the first time, thus requiring two doses of vaccine separated by at least 28 days.
Recommended Content:
Influenza, Northern Hemisphere
Publication
2/10/2020
The purpose of this standing order is to reduce morbidity and mortality from influenza by vaccinating adults who meet the criteria established by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) and the Department of Defense (DoD).
Recommended Content:
Influenza, Northern Hemisphere
Publication
8/12/2019
A list of available influenza vaccines for the 2019-20 flu season, along with age indications and other product specifications.
Recommended Content:
Influenza, Northern Hemisphere
Publication
5/14/2019
In preparation for the upcoming 2019-2020 influenza season, activities can follow this disposition guidance for influenza vaccine from the previous season.
Recommended Content:
Influenza, Northern Hemisphere
Policy
ASD(HA) memo detailing the forthcoming immunization requirements for the 2018-19 influenza season.
Showing results 1 - 15
Page 1 of 2